+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Microbial Fermentation Technology Market Size, Share & Industry Trends Analysis Report by Application, End User, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 85 Pages
  • March 2023
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5778720
The Europe Microbial Fermentation Technology Market should witness market growth of 5.2% CAGR during the forecast period (2022-2028).

Due to the microbial biopharmaceutical industry's explosive rise over the last few years, the microbial fermentation technologymarket has seen an increase in demand. The advantages of utilizing microbial organisms in production processes over mammalian cell culture, such as faster development times, higher expression levels, and lower medium costs, have greatly influenced this interest. In general, microbial fermentation technology delivers cheaper production costs, higher yields, quicker development, improved scalability, decreased fluctuation between batches, and faster yields.

The industry is also expected to rise with the demand for microbiological contract manufacturing services. Currently, more than 115 business owners are actively providing microbial fermentation services. Due to the presence of reputable companies like Lonza, AbbVie Contract Manufacturing, and others, the industry is, therefore, very fragmented. The presence of so many service providers is anticipated to fuel market expansion in the upcoming years.

The European Medicines Agency, for instance, has developed a comprehensive list of accessibility guidelines and opportunities for CDMO participation during the development stage of a medical product (EMA). The EMA gives drug researchers several opportunities for early consultation and discussion before suggesting a marketing authorization application. This is intended to offer regulatory and scientific help for developing applications and ensuring a smooth validation and assessment process. In addition, government funding and growing CVD awareness in the region are driving the market for microbial fermentation technology to expand.

The Germany market dominated the Europe Microbial Fermentation Technology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,249.6 million by 2028. The UK market is anticipated to grow at a CAGR of 4.3% during (2022-2028). Additionally, The France market would experience a CAGR of 6% during (2022-2028).

Based on Application, the market is segmented into Antibiotics, Recombinant Proteins, Enzymes, Monoclonal Antibodies, Probiotics Supplements, Vaccines, Biosimilars, Small Molecules and Others. Based on End-user, the market is segmented into CMOs & CDMOs, Bio-Pharmaceutical Companies, Contract Research Organizations (CROs) and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Biocon Limited, BioVectra Inc. (H.I.G. Capital, LLC), Danone S.A., F. Hoffmann-La Roche Ltd., Koninklijke DSM N.V., Lonza Group AG, Novozymes A/S (Novo Holdings A/S), Corbion N.V., and Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN).

Scope of the Study

By Application

  • Antibiotics
  • Recombinant Proteins
  • Enzymes
  • Monoclonal Antibodies
  • Probiotics Supplements
  • Vaccines
  • Biosimilars
  • Small Molecules
  • Others

By End-user

  • CMOs & CDMOs
  • Bio-Pharmaceutical Companies
  • Contract Research Organizations (CROs)
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Biocon Limited
  • BioVectra Inc. (H.I.G. Capital, LLC)
  • Danone S.A.
  • F. Hoffmann-La Roche Ltd.
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Novozymes A/S (Novo Holdings A/S)
  • Corbion N.V.
  • Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Microbial Fermentation Technology Market, by Application
1.4.2 Europe Microbial Fermentation Technology Market, by End-user
1.4.3 Europe Microbial Fermentation Technology Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Microbial Fermentation Technology Market
Chapter 4. Europe Microbial Fermentation Technology Market by Application
4.1 Europe Antibiotics Market by Country
4.2 Europe Recombinant Proteins Market by Country
4.3 Europe Enzymes Market by Country
4.4 Europe Monoclonal Antibodies Market by Country
4.5 Europe Probiotics Supplements Market by Country
4.6 Europe Vaccines Market by Country
4.7 Europe Biosimilars Market by Country
4.8 Europe Small Molecules Market by Country
4.9 Europe Others Market by Country
Chapter 5. Europe Microbial Fermentation Technology Market by End-user
5.1 Europe CMOs & CDMOs Market by Country
5.2 Europe Bio-Pharmaceutical Companies Market by Country
5.3 Europe Contract Research Organizations (CROs) Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Microbial Fermentation Technology Market by Country
6.1 Germany Microbial Fermentation Technology Market
6.1.1 Germany Microbial Fermentation Technology Market by Application
6.1.2 Germany Microbial Fermentation Technology Market by End-user
6.2 UK Microbial Fermentation Technology Market
6.2.1 UK Microbial Fermentation Technology Market by Application
6.2.2 UK Microbial Fermentation Technology Market by End-user
6.3 France Microbial Fermentation Technology Market
6.3.1 France Microbial Fermentation Technology Market by Application
6.3.2 France Microbial Fermentation Technology Market by End-user
6.4 Russia Microbial Fermentation Technology Market
6.4.1 Russia Microbial Fermentation Technology Market by Application
6.4.2 Russia Microbial Fermentation Technology Market by End-user
6.5 Spain Microbial Fermentation Technology Market
6.5.1 Spain Microbial Fermentation Technology Market by Application
6.5.2 Spain Microbial Fermentation Technology Market by End-user
6.6 Italy Microbial Fermentation Technology Market
6.6.1 Italy Microbial Fermentation Technology Market by Application
6.6.2 Italy Microbial Fermentation Technology Market by End-user
6.7 Rest of Europe Microbial Fermentation Technology Market
6.7.1 Rest of Europe Microbial Fermentation Technology Market by Application
6.7.2 Rest of Europe Microbial Fermentation Technology Market by End-user
Chapter 7. Company Profiles
7.1 Biocon Limited
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent Strategies and Developments
7.1.5.1 Acquisition and Mergers
7.2 BioVectra Inc. (H.I.G. Capital, LLC)
7.2.1 Company Overview
7.2.2 Recent Strategies and Developments
7.2.2.1 Partnerships, Collaborations, and Agreements
7.2.2.2 Product Launches and Product Expansions
7.2.2.3 Geographical Expansions
7.3 Danone S.A.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Category and Regional Analysis
7.3.4 Recent Strategies and Developments
7.3.4.1 Geographical Expansions
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Koninklijke DSM N.V.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent Strategies and Developments
7.5.5.1 Acquisition, Joint Venture and Mergers
7.6 Lonza Group AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.7 Novozymes A/S (Novo Holdings A/S)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent Strategies and Developments
7.7.5.1 Product Launches and Product Expansions
7.8 Corbion N.V.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)
7.9.1 Company Overview

Companies Mentioned

  • Biocon Limited
  • BioVectra Inc. (H.I.G. Capital, LLC)
  • Danone S.A.
  • F. Hoffmann-La Roche Ltd.
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Novozymes A/S (Novo Holdings A/S)
  • Corbion N.V.
  • Bangalore Biotech Labs Pvt. Ltd. (BiOZEEN)

Methodology

Loading
LOADING...